CEL-SCI Co. (NYSEAMERICAN:CVM) was the target of a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 462,000 shares, a drop of 11.8% from the November 15th total of 524,023 shares. Currently, 4.2% of the company’s shares are sold short. Based on an average daily volume of 166,547 shares, the short-interest ratio is currently 2.8 days.

CEL-SCI (CVM) opened at $1.85 on Friday. CEL-SCI has a twelve month low of $1.46 and a twelve month high of $4.57.

In other news, Director Vicente Benjamin Asuncion sold 160,000 shares of the firm’s stock in a transaction on Tuesday, October 17th. The stock was sold at an average price of $0.39, for a total value of $62,400.00.

Separately, Dawson James reiterated a “neutral” rating on shares of CEL-SCI in a report on Monday, October 16th.

ILLEGAL ACTIVITY NOTICE: This report was reported by Watch List News and is the property of of Watch List News. If you are reading this report on another website, it was illegally stolen and republished in violation of U.S. & international copyright law. The correct version of this report can be read at https://www.watchlistnews.com/cel-sci-co-cvm-sees-large-decline-in-short-interest/1768912.html.

About CEL-SCI

CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines.

Receive News & Ratings for CEL-SCI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEL-SCI and related companies with MarketBeat.com's FREE daily email newsletter.